Before the Buzz, there's the Investor Forum. BIO Investor Forum 2007 - Preliminary Program - October 9-11, 2007 - San Francisco

Solicitation

Overview

BIO Investor Forum 2007 showcases leading public and private biotechnology companies. The conference features companies to watch and those challenging the category leaders and redefining therapeutic options. This year’s event includes:

More than 230 public and private company presentations
Fourteen panels led by industry experts
One-on-one meetings
Q&A sessions with presenting companies
Premier opportunity to network with industry executives and investors focused exclusively on biotechnology

Theraputic Workshops

Alzheimer’s Disease – Novel Mechanisms and Targets Renewing the Future for Patients
Hepatitis C– Where Are We Really Going with Future
Treatment Paradigms?
Obesity Management – The Thick and Thin of New
Targets and Treatments
Advances in Neuropsychiatry – Anxiety, Depression, Psychoses: New Solutions to Complex Disorders
The Odd Couple – Marrying Chemotherapy with
Targeted Therapies
Turning the Heat Up on Cancer – New Technologies
to Enhance Antibodies
Rheumatoid Arthritis and Inflammatory Diseases –
Clinical Perspective on New Treatment Paradigms and Targets
From Cancer Vaccines to Adjuvants – Insights into the
Future of Immunotherapy and Cancer

Business Roundtables

Crossover Investing
FDA Reforms
IPO & Exit Strategies
Pharma Pipelines
PIPES
Shareholder Activism

For more program information, visit investorforum.bio.org.

Agenda

BIO Investor Forum 2007 will run from 8 a.m., Wednesday, October 10th to 6:30 p.m., Thursday, October 11th. For a full conference agenda click here.

Presenting Companies*

ACADIA Pharmaceuticals
Accera
Acologix
Acretia
Acusphere
ADVENTRX Pharmaceuticals
Aerovance
Affymax
Alba Therapeutics Corporation
Alexza Pharmaceuticals
Alfacell Corporation
Algeta ASA
Allon Therapeutics
Alnylam Pharmaceuticals
Alseres Pharmaceuticals
Ambit
Anadys Pharmaceuticals
Anesiva
Antares Pharma
Arena Pharmaceuticals
Argenes
Argos Therapeutics
ArQule
AtheroGenics
Avalon Pharmaceuticals
AVANT Immunotherapeutics
Avicena Group
Avigen
Bayhill Therapeutics
BioCryst Pharmaceuticals
Biodel
BioMimetic Therapeutics
Biomira
Bionovo
BioSante Pharmaceuticals
BioSeek
Cadence Pharmaceuticals
Cara Therapeutics
Cardium Therapeutics Inc
Catalyst Biosciences
Cell Genesys
Cell Therapeutics
Cellerant Therapeutics
Ceregene
Cerimon Pharmaceuticals
Chelsea Therapeutics
Cleveland BioLabs
CombinatoRx, Incorporated
Curis
Cyclacel Pharmaceuticals
Cytochroma
Cytogen Corporation
Cytokinetics
CytRx Corporation
deCODE genetics
Diffusion Pharmaceuticals
Direvo Biotech AG
DURECT Corporation
Elixir Pharmaceuticals
Elusys Therapeutics
Emergent BioSolutions
EntreMed
EpiCept Corporation
Ercole Biotech
Exelixis
EyeGate Pharma
Faust Pharmaceuticals S.A.
FoldRx Pharmaceutical
Gemin X Biotechnologies
Genaera Corporation
GeneEx
Genomic Health
GenVec
Geron Corporation
GlobeImmune
GlycoMimetics
GTC Biotherapeutics
Hana Biosciences
Idera Pharmaceuticals
Illumigen Biosciences
ImmunoGen
Infinity Pharmaceuticals
Inhibitex
Inimex Pharmaceuticals
INNOVIVE Pharmaceuticals
Inotek Pharmaceuticals Corp.
Inovio Biomedical
Insmed Incorporated
Intercept Pharmaceuticals
InterGenetics Incorporated
Intradigm Corporation
Introgen Therapeutics

JJ Pharma
Juvaris BioTherapeutics
KAI Pharmaceuticals
KaloBios Pharmaceuticals
KineMed
Kinexis
Koronis Pharmaceuticals
Kosan Biosciences
Lexicon Pharmaceuticals
Limerick NeuroSciences
Luminex Corporation
M's Science Corp.
Marinus Pharmaceuticals
MediciNova
Medicure Inc
Meditrina Pharmaceuticals
Medivation
MethylGene
Micromet
Momenta Pharmaceuticals
Nabi Biopharmaceuticals
Nanospectra Biosciences
Nektar Therapeutics
Neose Technologies
Neotropix
Neuro Hitech
NexBio
NovaDel Pharma
Nucleonics
NuPathe
Nventa Biopharmaceuticals Corporation
OMRIX Biopharmaceuticals
OncoGenex Technologies
Oncolytics Biotech
Onconova Therapeutics
Onyx Pharmaceuticals
Orexigen Therapeutics
Osteologix
Oxigene
Pacgen Biopharmaceuticals Corporation
Palatin Technologies
Penwest Pharmaceuticals
Peptech Limited / EvoGenix
Peptimmune
Peregrine Pharmaceuticals
PharmaEssentia Corp.
PharmAthene
Phase Bioscience
Poniard Pharmaceuticals
Probiodrug AG
Protein Sciences Corp.
Protherics
Protox Therapeutics
Raven biotechnologies
Receptor BioLogix
RegeneRx Biopharmaceuticals
RHEI Pharmaceuticals
Rigel Pharmaceuticals
Rosetta Genomics
Sangamo BioSciences
SensiGen LLC
Serenex
SGX Pharmaceuticals
Spectrum Pharmaceuticals
SuperGen
Surface Logix
Synvista Therapeutics
Targacept
Targanta Therapeutics
Target Discovery
Targeted Genetics Corporation
Tercica
TOPIGEN Pharmaceuticals
Twinstrand Therapeutics
Unibioscreen
Ventaira Pharmaceuticals
Verenium Corporation
VIA Pharmaceuticals
ViaCell
Vical Incorporated
VioQuest Pharmaceuticals
VIVUS
WuXi Pharmatech
Xanthus Pharmaceuticals
XOMA
ZIOPHARM Oncology
ZymoGenetics

Helix Sponsors
Ernst & Young, LLP
Merck & Co, Inc
Pfizer, Inc

Program Sponsor
MDB Capital

Conference Sponsors
Bio World
Heller Ehrman, LLP
VWR International

*as of 9/5/07

Executive Workshop

Prior to BIO Investor Forum 2007, BIO will offer a workshop designed for CEOs and senior biotech executives to enhance their presentations and presentation skills. For more information on this workshop held at the Palace Hotel on October 9th, visit exectraining.bio.org.